Nido Biosciences
Boston, US · Founded 2018 · Delaware corporation
Founders & leadership
JB
Jamil BegNamed on SEC filing
EE
Elliot EhrichNamed on SEC filing
Board
AS
Andrew SchwabBoard director
Reported raises · per SEC filings
Form D private placements$22.4M disclosed across 2 rounds · 2019–2020
▶$18.4MraisedSep 2020 · 6 investors · OtherRule 506(b)
▶$18.4MraisedSep 2020 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew HedinDirector
- Jamil BegExecutive Officer, Director
- Jacqueline GrantDirector
- Offering amount
- $46M
- Amount sold
- $18.4M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$4MraisedSep 2019 · 1 investors · OtherRule 506(b)
▶$4MraisedSep 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jamil BegExecutive Officer, Director
- Elliot EhrichDirector
- Andrew SchwabDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nido Biosciences raised?
- Nido Biosciences has disclosed $22.4M raised across 2 rounds.
- Where is Nido Biosciences headquartered?
- Nido Biosciences is headquartered in Boston, US.